This page shows the latest constipation news and features for those working in and with pharma, biotech and healthcare.
dose. The most common side effects were constipation, nausea, dry mouth, dyspepsia and vomiting.
Shares in Ardelyx rocketed 72% on the back of the new study on the prospect of a second indication for tenapanor to follow constipation associated with IBS, which is under review
Approval by China’s NMPA for adults with irritable bowel syndrome with constipation (IBS-C) opens up the country's huge market to the treatment. ... This approval is incredibly important as it brings a new option to treat some of the bothersome
Approval is boost as Takeda takeover nears completion. Shire has the US approval it needs for Motegrity, a drug for chronic idiopathic constipation (CIC) that will compete with drugs like
HAE, prucalopride (SHP555) for chronic idiopathic constipation, and calaspargase pegol (SHP663) for the treatment of acute lymphoblastic leukaemia (ALL).
As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... Amitizia is the prize asset in the deal, with FDA approvals in hand for three indications - chronic idiopathic
More from news
Approximately 8 fully matching, plus 67 partially matching documents found.
If we don’t drink enough water, it can lead to headaches, constipation, tiredness and more serious problems, such as urinary infections and kidney disease.
Diarrhoea, constipation, flatulence, leaky bladder, vaginal dryness - it’s all fertile territory.
His pioneering research culminated in the drug, Trulance, which has received FDA approval and is being used to treat irritable bowel syndrome and chronic constipation.
$110. AstraZeneca/ Kyowa Hakko Kirin. Opioid-induced constipation – Moventig. Licence. $70.
years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome.
More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.
irritable bowel syndrome and constipation.
Appointment follows nearly two years as global brand manager for constipation treatment Movicol. ... Hockey's promotion comes after nearly two years as global brand manager for constipation treatment Movicol since joining Norgine in 2011.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...